HD-OPM Archive
Topics › Infections & vaccines

Recombinant shingles vaccine linked to fewer cardiovascular events in Nature Medicine

Louis Nervegna · Aug 30, 2026 · ♥ 22 reactions · 3 comments · original Facebook post
Infections & vaccinesHeart attack, stroke & procedures
AI summary & key facts

Louis shares a 2026 Nature Medicine study comparing recombinant (Shingrix) and live attenuated shingles vaccines as a natural experiment. The recombinant vaccine was associated with lower incidence of cardiovascular events, adding to possible Alzheimer's protection.

This was just published.

In addition to possible protection against Alzheimer’s, the latest shingles vaccine (Shingrix) might also protect against CVD.

Link to journal paper:

Paper · Nature Medicine · 2026Recombinant shingles vaccination and the risk of cardiovascular eventsA natural experiment comparing recipients of the live attenuated versus recombinant herpes zoster vaccines found that the recombinant vaccine was associated with a lower incidence of cardiovascular events across 7 years of follow-up.nature.com

#shinglesHD #cvdHD #shingrixHD #inflammationHD

This content isn't available right now

When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.

Research cited

← newer: 2026 ESC guidelines: manage CVD and CKD together as one cardolder: REACT in NEJM: 57% of adults have atherosclerosis and age is →